DK0769056T3 - Ikke-splejsende verianter af gp350/220 - Google Patents

Ikke-splejsende verianter af gp350/220

Info

Publication number
DK0769056T3
DK0769056T3 DK95916984T DK95916984T DK0769056T3 DK 0769056 T3 DK0769056 T3 DK 0769056T3 DK 95916984 T DK95916984 T DK 95916984T DK 95916984 T DK95916984 T DK 95916984T DK 0769056 T3 DK0769056 T3 DK 0769056T3
Authority
DK
Denmark
Prior art keywords
protein
splicing variants
sequences
vectors
proteins
Prior art date
Application number
DK95916984T
Other languages
Danish (da)
English (en)
Inventor
Richard Spaete
Winthrop T Jackman
Original Assignee
Aviron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aviron Inc filed Critical Aviron Inc
Application granted granted Critical
Publication of DK0769056T3 publication Critical patent/DK0769056T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Polarising Elements (AREA)
  • Paper (AREA)
DK95916984T 1994-04-18 1995-04-13 Ikke-splejsende verianter af gp350/220 DK0769056T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22929194A 1994-04-18 1994-04-18
PCT/US1995/004611 WO1995028488A1 (en) 1994-04-18 1995-04-13 NON-SPLICING VARIANTS OF gp350/220

Publications (1)

Publication Number Publication Date
DK0769056T3 true DK0769056T3 (da) 2002-04-02

Family

ID=22860582

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95916984T DK0769056T3 (da) 1994-04-18 1995-04-13 Ikke-splejsende verianter af gp350/220

Country Status (25)

Country Link
US (3) US6054130A (ja)
EP (1) EP0769056B1 (ja)
JP (4) JP3447743B2 (ja)
KR (1) KR100380953B1 (ja)
CN (2) CN1118573C (ja)
AT (1) ATE210184T1 (ja)
AU (1) AU707837B2 (ja)
BR (1) BR9507473A (ja)
CA (1) CA2187908C (ja)
CZ (1) CZ292283B6 (ja)
DE (1) DE69524415T2 (ja)
DK (1) DK0769056T3 (ja)
ES (1) ES2170144T3 (ja)
FI (2) FI118224B (ja)
HU (1) HU221647B1 (ja)
LV (1) LV11803B (ja)
MY (1) MY114769A (ja)
NO (1) NO319382B1 (ja)
PL (1) PL181881B1 (ja)
PT (1) PT769056E (ja)
RU (1) RU2178807C2 (ja)
SK (1) SK283446B6 (ja)
TW (1) TW496897B (ja)
UA (1) UA47403C2 (ja)
WO (1) WO1995028488A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692749B1 (en) * 1994-04-18 2004-02-17 Medimmune Vaccines, Inc. Non-splicing variants of gp350/220
MY114769A (en) 1994-04-18 2003-01-31 Aviron Inc Non-splicing variants of gp350/220
US6458939B1 (en) * 1996-03-15 2002-10-01 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
AUPO784197A0 (en) * 1997-07-10 1997-08-07 Csl Limited Treatment of nasopharyngeal carcinoma
AU735763B2 (en) * 1997-12-05 2001-07-12 Immune Response Corporation, The Novel vectors and genes exhibiting increased expression
WO1999064603A2 (en) * 1998-06-12 1999-12-16 Henry M. Jackson Foundation For The Advancement Of Military Medicine ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220
GB0210682D0 (en) * 2002-05-09 2002-06-19 Glaxosmithkline Biolog Sa Novel use
EP2631240A1 (en) * 2009-05-22 2013-08-28 Intelligent Medical Devices, Inc. Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of Cytomegalovirus and Epstein-Barr virus
US10461635B1 (en) * 2018-05-15 2019-10-29 Analog Devices Global Unlimited Company Low VIN high efficiency chargepump

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3069310D1 (en) * 1980-11-03 1984-10-31 Itt Ind Gmbh Deutsche Binary mos ripple carry parallel adder/subtractor and appropriate adding/subtracting stage
US4707358A (en) * 1984-01-30 1987-11-17 The University Of Chicago Vaccine against Epstein-Barr Virus
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
EP0173254B1 (en) * 1984-08-23 1991-07-24 Hans Joachim Wolf Dna sequences of the ebv genome, recombinant dna molecules, processes for producing ebv-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
CA2090295A1 (en) * 1992-02-03 1993-08-04 Anthony B. Nesburn Process for the expression of herpes simplex virus type 1 glycoprotein e and methods of use
AU1648092A (en) * 1992-03-19 1993-10-21 Cancer Research Campaign Technology Limited Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins
US5474914A (en) * 1992-07-29 1995-12-12 Chiron Corporation Method of producing secreted CMV glycoprotein H
MY114769A (en) 1994-04-18 2003-01-31 Aviron Inc Non-splicing variants of gp350/220

Also Published As

Publication number Publication date
MY114769A (en) 2003-01-31
JP2005333990A (ja) 2005-12-08
JP2003230396A (ja) 2003-08-19
HUT75831A (en) 1997-05-28
FI964186A0 (fi) 1996-10-18
US6054130A (en) 2000-04-25
US6458364B1 (en) 2002-10-01
CN100415895C (zh) 2008-09-03
DE69524415T2 (de) 2002-08-01
JPH10501687A (ja) 1998-02-17
UA47403C2 (uk) 2002-07-15
US5824508A (en) 1998-10-20
JP3447743B2 (ja) 2003-09-16
JP2004290199A (ja) 2004-10-21
HU221647B1 (hu) 2002-12-28
PL181881B1 (pl) 2001-09-28
CZ292283B6 (cs) 2003-08-13
CN1118573C (zh) 2003-08-20
AU2383895A (en) 1995-11-10
ES2170144T3 (es) 2002-08-01
NO964431D0 (no) 1996-10-18
CZ305496A3 (en) 1997-10-15
SK283446B6 (sk) 2003-07-01
KR100380953B1 (ko) 2003-10-10
NO964431L (no) 1996-12-11
FI20075338A (fi) 2007-05-10
WO1995028488A1 (en) 1995-10-26
RU2178807C2 (ru) 2002-01-27
PL316941A1 (en) 1997-02-17
NO319382B1 (no) 2005-07-25
CA2187908C (en) 2002-09-17
HU9602894D0 (en) 1996-12-30
AU707837B2 (en) 1999-07-22
SK134396A3 (en) 1997-06-04
CN1152940A (zh) 1997-06-25
JP4317786B2 (ja) 2009-08-19
CN1495262A (zh) 2004-05-12
ATE210184T1 (de) 2001-12-15
LV11803B (en) 1998-01-20
BR9507473A (pt) 1997-09-23
EP0769056A4 (en) 1998-03-04
LV11803A (lv) 1997-06-20
PT769056E (pt) 2002-05-31
FI118224B (fi) 2007-08-31
DE69524415D1 (de) 2002-01-17
EP0769056B1 (en) 2001-12-05
TW496897B (en) 2002-08-01
CA2187908A1 (en) 1995-10-26
FI964186A (fi) 1996-12-17
EP0769056A1 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
FI20075338A (fi) gb350/220:n ei silmukoivia muutoksia
CA2263889A1 (en) P-selectin ligand proteins
WO1989009787A3 (en) Osteogenic devices
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
AU2058888A (en) Variants of bovine pancreatic trypsin inhibitor produced by recombinant DNA technology, process, expression vector and recombinant host therefor and pharmaceutical use thereof
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
AU8258591A (en) Human mk gene and protein sequence
WO1995030001A3 (en) Novel p-selectin ligand protein
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
AU8811298A (en) Novel peptides and polypeptides useful for regenerating the nervous system
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
CA2163805A1 (en) Novel activating factor of leukocytes
AU4034095A (en) Cyclohexapeptides and their mixtures, a process for preparing them, and their use
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU690729C (en) Process for the preparation of polycondensates of amino acids and the biodegradable polypeptide hydrolysates thereof, and their use in detergent compositions